PD Dr. med. Christoph Hammerstingl - Kardiologie, Köln - Publikationen

Publikationsliste

1) Sedaghat A, Schrickel JW, Andrié R, Schueler R, Nickenig G, Hammerstingl C. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device. J Am Coll Cardiol EP 2016; in press.

2) Nickenig G, Hammerstingl C, Schueler R, Topilsky Y, Grayburn PA, Vahanian A, Messika-Zeitoun D, Urena Alcazar M, Baldus S, Volker R, Huntgeburth M, Alfieri O, Latib A, La Canna G, Agricola E, Colombo A, Kuck KH, Kreidel F, Frerker C, Tanner FC, Ben-Yehuda O, Maisano F.Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2039-2047.

3) Schueler R, Malasa M, Hammerstingl C, Nickenig G. Transcatheter interventions for tricuspid regurgitation: MitraClip. EuroIntervention. 2016 Sep 18;12(Y):Y108-9.

4) Öztürk C, Schueler R, Weber M, Welz A, Werner N, Nickenig G, Hammerstingl C. Sympathetic Activity in Patients With Secondary Symptomatic Mitral Regurgitation or End-Stage Systolic Heart Failure. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2050-2057.

5) Sedaghat A, Neumann N, Schahab N, Sinning JM, Hammerstingl C, Pingel S, Schaefer C, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Werner N. Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation. Circ Cardiovasc Interv. 2016 Aug;9(8).

6) Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A; X-TRA study and CLOT-AF registry investigators. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J. 2016 Aug;178:126-34.

7) Sedaghat A, Falkenberg N, Sinning JM, Kulka H, Hammerstingl C, Nickenig G, Oldenburg J, Pötzsch B, Werner N. TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia. Int J Cardiol. 2016 Oct 15;221:719-25.

8) Arsalan M, Agricola E, Alfieri O, Baldus S, Colombo A, Filardo G, Hammerstingl C, Huntgeburth M, Kreidel F, Kuck KH, LaCanna G, Messika-Zeitoun D, Maisano F, Nickenig G, Pollock BD, Roberts BJ, Vahanian A, Grayburn PA. Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral Annulus. Am J Cardiol. 2016 Sep 1;118(5):744-9.

9) Nickenig G, Schueler R, Dager A, Martinez Clark P, Abizaid A, Siminiak T, Buszman P, Demkow M, Ebner A, Asch FM, Hammerstingl C. Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System. J Am Coll Cardiol. 2016 Jun 28;67(25):2927-36.

10) Pizarro C, Kluenker F, Hammerstingl C, Skowasch D. Diagnostic value of speckle-tracking echocardiography in confirmed cardiac sarcoidosis. Clin Res Cardiol 2016 June 6.

11) Witte C, Meyer Zur Heide Genannt Meyer-Arend JU, Andrie R, Schrickel JW, Hammerstingl C, Schwab JO, Nickenig G, Skowasch D, Pizarro C. Heart Rate Variability and Arrhythmic Burden in Pulmonary Hypertension. Adv Exp Med Biol 2016 May 31.

12) Pizarro C, Meyer Zur Heide Genannt Meyer-Arend, Schueler R, Hammerstingl C, Tuleta I, Nickenig G, Skowasch D. Impact of macitentan on right ventricular myocardial function in pulmonary arterial hypertension. Int J Cardiol 2016 July 1;214:438-41.

13) Sinning JM, Stundl A, Pingel S, Weber M, Sedaghat A, Hammerstingl C, Vasa-Nicotera M, Mellert F, Schiller W, Kovac J, Welz A, Grube E, Werner N, Nickenig G. Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2016 April 11;9(7):700-11.

14) Tuleta I, Skowasch D, Krycki J, Pizarro C, Hammerstingl C, Weber M, Schahab N, Nickenig G, Schaefer C, Pingel S. Obstructive Sleep Apnea Is Related to Increased Arterial Stiffness in Ultrasound Speckle-Tracking Analysis. Adv Exp Med Biol 2016;910:9-14.

15) Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J, Hansen L, Riess FC, Bijuklic K. Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System. J Am Coll Cardiol 2016 February 23;67(7):889-90.

16) Pizarro C, Goebel A, Dabir D, Hammerstingl C, Pabst S, Grohe C, Fimmers R, Stoffel-Wagner B, Nickenig G, Schild H, Skowasch D, Thomas D. Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 2015;32(4):325-35.

17) Schueler R, Werner N, Nickenig G, Hammerstingl C. Catheter-based complete "Alfieri-Stich" via interventional annuloplasty and edge-to-edge repair for degenerative mitral regurgitation. Eur Heart J 2016 February 2.

18) Tuleta I, Pingel S, Biener L, Pizarro C, Hammerstingl C, Ozturk C, Schahab N, Grohe C, Nickenig G, Schaefer C, Skowasch D. Atherosclerotic Vessel Changes in Sarcoidosis. Adv Exp Med Biol 2016;910:23-30.

19) Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J 2016 March 7;37(10):849-53.

20) Fuchs FC, Hammerstingl C, Werner N, Grube E, Nickenig G. Catheter-Based Edge-to-Edge Mitral Valve Repair After Partial Rupture of Surgical Annuloplasty Ring. JACC Cardiovasc Interv 2015 December 28;8(15):e263-e264.

21) Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La CG, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck KH. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 2016 March 7;37(10):817-25.

22) Stundl A, Rademacher MC, Descoups C, Weber M, Sedaghat A, Grube M, Hammerstingl C, Mellert F, Vasa-Nicotera M, Welz A, Grube E, Werner N, Nickenig G, Sinning JM. Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis. EuroIntervention 2016 February 20;11(10):1140-7.

23) Fuchs FC, Hammerstingl C, Sinning JM, Mellert F, Werner N, Grube E, Nickenig G. Antegrade transcatheter mitral valve-in-valve implantation with combined atrial septal defect closure. Clin Res Cardiol 2016 May;105(5):460-2.

24) Sinning JM, Wollert KC, Sedaghat A, Widera C, Radermacher MC, Descoups C, Hammerstingl C, Weber M, Stundl A, Ghanem A, Widder J, Vasa-Nicotera M, Mellert F, Schiller W, Bauersachs J, Zur B, Holdenrieder S, Welz A, Grube E, Pencina MJ, Nickenig G, Werner N, Kempf T. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J 2015 October;170(4):821-9.

25) Nickenig G, Hammerstingl C. The Mitralign transcatheter direct mitral valve annuloplasty system. EuroIntervention 2015 September;11 Suppl W:W62-W63.

26) Schueler R, Nickenig G, May AE, Schillinger W, Bekeredjian R, Ouarrak T, Schofer J, Hehrlein C, Sievert H, Boekstegers P, Lubos E, Hoffmann R, Baldus S, Senges J, Hammerstingl C. Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. EuroIntervention 2015 September 8;11(5).

27) Schueler R, Hammerstingl C. Reply: Iatrogenic Atrial Septal Defect After MitraClip Therapy. JACC Cardiovasc Interv 2015 August 17;8(9):1271-2.

28) Schueler R, Hammerstingl C. Reply: Quantitative Evaluation of Residual Atrial Septal Defect Following Transseptal Catheterization for Intracardiac Interventional Procedures. JACC Cardiovasc Interv 2015 August 17;8(9):1269-70.

29) Malasa M, Werner N, Nickenig G, Hammerstingl C. Transcatheter tricuspid valve repair in a patient with isolated functional tricuspid valve regurgitation. Eur Heart J 2016 March 7;37(10):855.

30) Linhart M, Sinning JM, Ghanem A, Kozhuppakalam FJ, Fistera R, Hammerstingl C, Pizarro C, Grube E, Werner N, Nickenig G, Skowasch D. Prevalence and Impact of Sleep Disordered Breathing in Patients with Severe Aortic Stenosis. PLoS One 2015;10(7):e0133176.

31) Tiyerili V, Nickenig G, Hammerstingl C. Catch of the day: interventional device retrieval after late embolization of an Amplatzer cardiac plug left atrial appendage occluder. Clin Res Cardiol 2015 December;104(12):1106-8.

32) Mellert F, Sinning JM, Werner N, Welz A, Grube E, Nickenig G, Hammerstingl C. First-in-man transapical mitral valve replacement using the Direct Flow Medical(R) aortic valve prosthesis. Eur Heart J 2015 August 14;36(31):2119.

33) Weber M, Bruggemann E, Schueler R, Momcilovic D, Sinning JM, Ghanem A, Werner N, Grube E, Schiller W, Mellert F, Welz A, Nickenig G, Hammerstingl C. Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol 2015 November;104(11):964-74.

34) Schwarze-Zander C, Pabst S, Hammerstingl C, Ohlig J, Wasmuth JC, Boesecke C, Stoffel-Wagner B, Carstensen A, Nickenig G, Strassburg CP, Rockstroh JK, Skowasch D, Schueler R. Pulmonary hypertension in HIV infection: a prospective echocardiographic study. HIV Med 2015 October;16(9):578-82.

35) Pizarro C, Schueler R, Hammerstingl C, Tuleta I, Nickenig G, Skowasch D. Impact of endoscopic lung volume reduction on right ventricular myocardial function. PLoS One 2015;10(4):e0121377.

36) Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, Morandi E, van EM, Cohen A. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J 2015 April;169(4):464-71.

37) Schueler R, Ozturk C, Wedekind JA, Werner N, Stockigt F, Mellert F, Nickenig G, Hammerstingl C. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. JACC Cardiovasc Interv 2015 March;8(3):450-9.

38) Sinning JM, Hammerstingl C, Schueler R, Neugebauer A, Keul S, Ghanem A, Mellert F, Schiller W, Muller C, Vasa-Nicotera M, Zur B, Welz A, Grube E, Nickenig G, Werner N. The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. EuroIntervention 2016 April 20;11(13):1522-9.

39) Pizarro C, Hammerstingl C, Schaefer C, Grohe C, Nickenig G, Skowasch D. [New therapeutic approaches to pulmonary embolism: trials' results and significance of direct oral anticoagulants]. Pneumologie 2015 February;69(2):99-110.

40) Ozturk C, Schueler R, Werner N, Nickenig G, Hammerstingl C. MitraClip procedure for the treatment of a pseudo-cleft in the posterior mitral leaflet. Eur Heart J Cardiovasc Imaging 2015 January;16(1):112.

41) Sinning JM, Vasa-Nicotera M, Werner N, Zimmer S, Mellert F, Welz A, Grube E, Nickenig G, Hammerstingl C. CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation. JACC Cardiovasc Interv 2014 July;7(7):e71-e72.

42) Schueler R, Momcilovic D, Weber M, Welz A, Werner N, Mueller C, Ghanem A, Nickenig G, Hammerstingl C. Acute changes of mitral valve geometry during interventional edge-to-edge repair with the MitraClip system are associated with midterm outcomes in patients with functional valve disease: preliminary results from a prospective single-center study. Circ Cardiovasc Interv 2014 June;7(3):390-9.

43) Schueler R, Werner N, Nickenig G, Hammerstingl C. Interventional closure of a mitral valvular leaflet defect after partial detachment of a carpentier perimount annuloplasty ring. JACC Cardiovasc Interv 2014 June;7(6):698-9.

44) Hammerstingl C, Schueler R, Weber M, Ghanem A, Werner N, Vasa NM, Thomas D, Mellert F, Schiller W, Schild HH, Welz A, Grube E, Nickenig G, Sinning JM. Three-dimensional imaging of the aortic valve geometry for prosthesis sizing prior to transcatheter aortic valve replacement. Int J Cardiol 2014 July 1;174(3):844-9.

45) Weber M, Mellert F, Nickenig G, Werner N, Hammerstingl C. Transapical transcatheter aortic valve replacement with simultaneous paravalvular leakage closure in a patient with severely degenerated aortic valve bioprosthesis. Eur Heart J Cardiovasc Imaging 2014 September;15(9):1058.

46) Sedaghat A, Nickenig G, Hammerstingl C. Left atrial appendage closure in a patient with atrial fibrillation after mechanical mitral valve replacement and cardio-embolic stroke despite effective oral anticoagulant therapy: a case report. Clin Res Cardiol 2014 July;103(7):587-9.

47) Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Mollmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB. Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 2014 August;103(8):631-40.

48) Asdonk T, Nickenig G, Hammerstingl C. Reduction of severe mitral regurgitation with the MitraClip system improves renal function in two patients presenting with acute kidney injury and progressive renal failure due to cardio renal syndrome. Catheter Cardiovasc Interv 2014 October 1;84(4):610-4.

49) Schueler R, Sinning JM, Zimmer S, Nickenig G, Hammerstingl C. Multimodality imaging for interventional planning and device closure of an atypical ventricular septal defect occurring late after myocardial infarction. Eur Heart J 2014 April;35(15):1007.

50) Flock A, Kornblum C, Hammerstingl C, Claeys KG, Gembruch U, Merz WM. Progressive cardiac dysfunction in Bethlem myopathy during pregnancy. Obstet Gynecol 2014 February;123(2 Pt 2 Suppl 2):436-8.

51) Sinning JM, Hammerstingl C, Chin D, Ghanem A, Schueler R, Sedaghat A, Bence J, Spyt T, Werner N, Kovac J, Grube E, Nickenig G, Vasa-Nicotera M. Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. EuroIntervention 2014 January 22;9(9):1042-9.

52) Sinning JM, Adenauer V, Scheer AC, Lema Cachiguango SJ, Ghanem A, Hammerstingl C, Sedaghat A, Muller C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N. Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation. EuroIntervention 2014 March 20;9(11):1309-16.

53) Hammerstingl C, Schueler R, Wiesen M, Momcilovic D, Pabst S, Nickenig G, Skowasch D. Impact of untreated obstructive sleep apnea on left and right ventricular myocardial function and effects of CPAP therapy. PLoS One 2013;8(10):e76352.

54) Ghanem A, Kocurek J, Sinning JM, Weber M, Hammerstingl C, Wagner M, Vasa-Nicotera M, Grube E, Werner N, Nickenig G. Novel approaches for prevention of stroke related to transcatheter aortic valve implantation. Expert Rev Cardiovasc Ther 2013 October;11(10):1311-20.

55) Ghanem A, Kocurek J, Sinning JM, Wagner M, Becker BV, Vogel M, Schroder T, Wolfsgruber S, Vasa-Nicotera M, Hammerstingl C, Schwab JO, Thomas D, Werner N, Grube E, Nickenig G, Muller A. Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013 December;6(6):615-24.

56) Linhart M, Pabst S, Fistera R, Ghanem A, Sinning JM, Hammerstingl C, Kozhuppakalam F, Grube E, Werner N, Nickenig G, Skowasch D. Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis. EuroIntervention 2013 December;9(8):923-8.

57) Hammerstingl C, Sinning JM, Schiller W, Buchbinder M, Nickenig G. Percutaneous implantation of a 26 mm Edwards SAPIEN-XT aortic valve prosthesis in a degenerated 30 mm mitral annuloplasty ring. Eur Heart J 2013 June;34(23):1748.

58) Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, Nickenig G, Werner N. The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 2013 November;102(11):821-9.

59) Sinning JM, Mellert F, Schiller W, Welz A, Nickenig G, Hammerstingl C. Transcatheter mitral valve replacement using a balloon-expandable prosthesis in a patient with calcified native mitral valve stenosis. Eur Heart J 2013 September;34(33):2609.

60) Linhart M, Lewalter T, Mittmann-Braun EL, Karbach NC, Andrie RP, Hammerstingl C, Fimmers R, Kreuz J, Nickenig G, Schrickel JW, Lickfett LM. Left atrial pressure as predictor for recurrence of atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol 2013 November;38(2):107-14.

61) Hammerstingl C, Nickenig G. Simultaneous closure of the left atrial appendage and a severe LVOT: atrial shunt defect. Eur Heart J Cardiovasc Imaging 2013 November;14(11):1118.

62) Storm KA, Hammerstingl C, Nickenig G, Becher UM, Tiyerili V. A 39-year-old woman with silent endocarditis of a caged-ball mitral valve. Eur Heart J Cardiovasc Imaging 2013 November;14(11):1116.

63) Sinning JM, Vasa-Nicotera M, Chin D, Hammerstingl C, Ghanem A, Bence J, Kovac J, Grube E, Nickenig G, Werner N. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol 2013 July 2;62(1):11-20.

64) Ghanem A, Muller A, Sinning JM, Kocurek J, Becker BV, Vogel M, Vasa-Nicotera M, Hammerstingl C, Schwab JO, Nahle CP, Thomas D, Wagner M, Grube E, Werner N, Nickenig G. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 2013 March;8(11):1296-306.

65) Sinning JM, Werner N, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, Nickenig G. Innovations and novel technologies in TAVI. Second generation transcatheter heart valves. Minerva Cardioangiol 2013 April;61(2):155-63.

66) Hammerstingl C, Potzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013 April;109(4):583-4.

67) Ghanem A, Muller A, Sinning JM, Kocurek J, Becker BV, Vogel M, Vasa-Nicotera M, Hammerstingl C, Schwab JO, Nahle CP, Thomas D, Wagner M, Grube E, Werner N, Nickenig G. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 2012 November 22.

68) Hammerstingl C, Schueler R, Welz A, Nickenig G. [Ischemic mitral regurgitation : pathomechanisms and current therapeutic options]. Internist (Berl) 2013 January;54(1):39-7, 49.

69) Sinning JM, Hammerstingl C, Vasa-Nicotera M, Grube E, Werner N, Nickenig G, Ghanem A. Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection. EuroIntervention 2012 September;8(5):640-1.

70) Pabst S, Hammerstingl C, Grau N, Kreuz J, Grohe C, Juergens UR, Nickenig G, Skowasch D. Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience. Adv Exp Med Biol 2013;755:299-305.

71) Hammerstingl C, Schueler R, Bors L, Momcilovic D, Pabst S, Nickenig G, Skowasch D. Diagnostic value of echocardiography in the diagnosis of pulmonary hypertension. PLoS One 2012;7(6):e38519.

72) Hammerstingl C, Nickenig G, Nitschmann S. [Oral factor Xa inhibitors or warfarin for stroke prophylaxis. ROCKET AF and ARISTOTLE studies]. Internist (Berl) 2012 July;53(7):893-6.

73) Schueler R, Sinning JM, Momcilovic D, Weber M, Ghanem A, Werner N, Nickenig G, Grube E, Hammerstingl C. Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. J Am Soc Echocardiogr 2012 August;25(8):827-34.

74) Lampe B, Hammerstingl C, Schwab JO, Mellert F, Stoffel-Wagner B, Grigull A, Fimmers R, Maisch B, Nickenig G, Lewalter T, Yang A. Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block. Clin Res Cardiol 2012 October;101(10):829-36.

75) Sinning JM, Vasa-Nicotera M, Werner N, Nickenig G, Hammerstingl C. Interventional closure of paravalvular leakage after transcatheter aortic valve implantation. Eur Heart J 2012 October;33(19):2498.

76) Omran H, Bauersachs R, Rubenacker S, Goss F, Hammerstingl C. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012 July;108(1):65-73.

77) Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohe C, Nickenig G, Woitas R, Skowasch D. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One 2012;7(4):e35310.

78) Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, Hausen S, Sedaghat A, Ghanem A, Muller C, Grube E, Nickenig G, Werner N. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 2012 March 27;59(13):1134-41.

79) Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Muller C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 2012 June;33(12):1459-68.

80) Hammerstingl C, Schueler R, Wiesen M, Momcilovic D, Pabst S, Nickenig G, Skowasch D. Effects of untreated obstructive sleep apnea on left and right ventricular myocardial function. Int J Cardiol 2012 March 22;155(3):465-9.

81) Rosenkranz S, Bonderman D, Buerke M, Felgendreher R, ten FH, Grunig E, de HF, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kuebler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J. Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011 December;154 Suppl 1:S34-S44.

82) Hammerstingl C, Nickenig G, Endlich M, Mellert F, Schiller W. Treatment of a severely degenerated mitral valve bioprosthesis with simultaneous transapical paravalvular leak closure and valve-in-valve implantation. Eur Heart J 2012 August;33(15):1976.


83) Hammerstingl C, Schwekendiek M, Momcilovic D, Schueler R, Sinning JM, Schrickel JW, Mittmann-Braun E, Nickenig G, Lickfett L. Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures. J Cardiovasc Electrophysiol 2012 March;23(3):247-55.

84) Hammerstingl C, Nickenig G, Weber S, Knuefermann P. A "small" defect with malignant effect. J Am Coll Cardiol 2011 September 13;58(12):e23.

85) Weber SU, Hammerstingl C, Mellert F, Baumgarten G, Putensen C, Knuefermann P. [Traumatic tricuspid valve insufficiency with right-to-left shunt: bridging using extracorporeal venovenous membrane oxygenation]. Anaesthesist 2012 January;61(1):41-6.

86) Hammerstingl C, Nickenig G, Grube E. Treatment of a degenerative stenosed CoreValve((R)) aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv 2012 April 1;79(5):748-55.

87) Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Nickenig G, Woitas R, Skowasch D. [Pulmonary hypertension in end-stage renal disease: three case reports]. Dtsch Med Wochenschr 2011 May;136(18):944-7.

88) Hammerstingl C, Omran H. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients. Europace 2011 September;13(9):1304-10.

89) Hammerstingl C, Bauriedel B, Stusser C, Momcilovic D, Tuleta I, Nickenig G, Skowasch D. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study. Eur J Med Res 2011 January 27;16(1):13-9.

90) Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010 November;3(11):1141-9.

91) Pabst S, Hammerstingl C, Nickenig G, Skowasch D. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.]. Pharm Unserer Zeit 2010 November;39(6):448-52.

92) Schueler R, Hammerstingl C, Sinning JM, Nickenig G, Omran H. Prognosis of octogenarians with severe aortic valve stenosis at high risk for cardiovascular surgery. Heart 2010 November;96(22):1831-6.

93) Rosenkranz S, Bonderman D, Buerke M, Felgendreher R, ten FH, Grunig E, de HF, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kubler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J. [Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr 2010 October;135 Suppl 3:S102-S114.

94) Flock A, Zobel A, Bauriedel G, Tuleta I, Hammerstingl C, Hofels S, Schuhmacher A, Maier W, Nickenig G, Skowasch D. Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thromb Res 2010 August;126(2):e83-e87.

95) Skowasch D, Urbach H, Bauriedel G, Hammerstingl C, Gockel A, Simon B, Schild HH, Nickenig G. Silent and apparent cerebral embolism after interventional closure of symptomatic patent foramen ovale. Int J Cardiol 2010 November 19;145(2):401-2.
96) Ghanem A, Muller A, Nahle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010 April 6;55(14):1427-32.

97) Hammerstingl C, Schmitz A, Fimmers R, Omran H. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry. Cardiovasc Ther 2009;27(4):230-8.

98) Miszalski-Jamka T, Kuntz-Hehner S, Schmidt H, Peter D, Miszalski-Jamka K, Hammerstingl C, Tiemann K, Ghanem A, Troatz C, Pasowicz M, Luderitz B, Omran H. Myocardial contrast echocardiography enhances long-term prognostic value of supine bicycle stress two-dimensional echocardiography. J Am Soc Echocardiogr 2009 November;22(11):1220-7.

99) Hammerstingl C, Omran H. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures. Thromb Haemost 2009 June;101(6):1085-90.#

100) Hammerstingl C, Werner N, Nickenig G. Symptomatic paravalvular leakage after mechanical aortic valve replacement in a critically ill patient: why not just "plug" the hole? Eur J Echocardiogr 2009 June;10(4):576-8.

101) Hammerstingl C, Omran H, Tripp C, Poetzsch B. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study. Thromb Haemost 2009 February;101(2):325-32.

102) Hammerstingl C, Lickfett L, Nickenig G. Real-time three-dimensional transoesophageal echocardiography for guidance of interventional closure of paravalvular leakage. Eur Heart J 2009 April;30(8):915.

103) Hammerstingl C, Ghanem A, Tiemann K. An unusual cause for recurrent syncope in a female adult with LEOPARD syndrome. Echocardiography 2009 May;26(5):596-7.

104) Hammerstingl C. Monitoring therapeutic anticoagulation with low molecular weight heparins: is it useful or misleading? Cardiovasc Hematol Agents Med Chem 2008 October;6(4):282-6.

105) Miszalski-Jamka T, Kuntz-Hehner S, Schmidt H, Miszalski-Jamka K, Hammerstingl C, Tiemann K, Ghanem A, Troatz C, Pasowicz M, Luderitz B, Omran H. Impact of previous myocardial infarction on the incremental value of myocardial contrast to two-dimensional supine bicycle stress echocardiography in evaluation of coronary artery disease. Int J Cardiol 2009 July 24;136(1):47-55.

106) Hammerstingl C, Lickfett L. Safety of single transseptal puncture for ablation of atrial fibrillation: retrospective study from a large cohort of patients. J Cardiovasc Electrophysiol 2008 May;19(5):E36.

107) Omran H, Hammerstingl C, Paar WD. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]. Med Klin (Munich) 2007 October 15;102(10):809-15.

108) Miszalski-Jamka T, Kuntz-Hehner S, Schmidt H, Hammerstingl C, Tiemann K, Ghanem A, Troatz C, Luderitz B, Omran H. Real time myocardial contrast echocardiography during supine bicycle stress and continuous infusion of contrast agent. Cutoff values for myocardial contrast replenishment discriminating abnormal myocardial perfusion. Echocardiography 2007 July;24(6):638-48.

109) Hammerstingl C, Tripp C, Schmidt H, von der RG, Omran H. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 2007 May;16(3):285-92.

110) Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Luderitz B, Lewalter T. Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk? Am Heart J 2006 August;152(2):362-5.

111) Linhart M, Lickfett L, Hammerstingl C, Tiemann K, Nickenig G, Lewalter T. Paroxysmal atrial flutter caused by cardiac lymphoma. Pacing Clin Electrophysiol 2006 June;29(6):682-4.

112) Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Atrial thrombi-a prospective follow-up study over 3 years with transesophageal echocardiography and cranial magnetic resonance imaging. Echocardiography 2006 May;23(5):388-94.

113) Rabe C, Balta Z, Wullner U, Heller J, Hammerstingl C, Tiemann K, Sommer T, Schepke M, Fischer HP, Sauerbruch T. Biliary metal stents and air embolism: a note of caution. Endoscopy 2006 June;38(6):648-50.

114) Omran H, Schmidt H, Hardung D, Hammerstingl C, von der RG, Haas S, Buttner R, Luderitz B. Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. J Interv Card Electrophysiol 2005 October;14(1):17-20.

115) Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr 2005 September;18(9):919-24.

116) Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr 2005 June;18(6):649-53.

117) Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005 June 7;45(11):1807-12.

118) Bernhardt P, Schmidt H, Hammerstingl C, Hackenbroch M, Sommer T, Luderitz B, Omran H. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. Am J Cardiol 2004 September 15;94(6):801-4.

119) Andrie R, Skowasch D, Schmidt H, Kuntz-Hehner S, Hammerstingl C, Ludwig M, Luderitz B, Bauriedel G. [Interventional catheter closure of persistent foramen ovale (PFO) in a patient with paradoxical embolism and Brugada's syndrome]. Dtsch Med Wochenschr 2004 May 21;129(21):1193-7.

120) Omran H, Hardung D, Schmidt H, Hammerstingl C, Luderitz B. Mechanical occlusion of the left atrial appendage. J Cardiovasc Electrophysiol 2003 September;14(9 Suppl):S56-S59.

121) Omran H, Hammerstingl C, Schmidt H, von der RG, Paar WD, Luderitz B. A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003 August;90(2):267-71.

122) Illien S, Maroto-Jarvinen S, von der RG, Hammerstingl C, Schmidt H, Kuntz-Hehner S, Luderitz B, Omran H. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart 2003 February;89(2):165-8.